Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations trials recruiting in New York

Fewer than 3 recruiting trials found.

All Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations trials nationally

1

Recruiting in New York

4

Cities with sites

Cities in New York

Commack 1Harrison 1Long Island City 1Uniondale 1

Recruiting trials in New York

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Commack, Harrison, Long Island City, Uniondale

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.